Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Strahm

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Blood|May 25, 2016
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experienceBeatriz Morillo-Gutierrez, Rita Beier, Kanchan Rao, et al.
Haematologica|August 16, 2023
Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndromeMiriam Erlacher, Felicia Andresen, Martina Sukova, et al.
Haematologica|December 9, 2017
Constitutional <i>SAMD9L</i> mutations cause familial myelodysplastic syndrome and transient monosomy 7Victor B Pastor, Sushree S Sahoo, Jessica Boklan, et al.
JCI Insight|May 22, 2024
Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemiaYari Giménez, Manuel Palacios, Rebeca Sánchez-Domínguez, et al.
Blood Advances|January 20, 2026
Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent yearsFelicia Andresen, Ayami Yoshimi, Peter Bader, et al.
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Blood|September 9, 2004
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trialFranco Locatelli, Peter Nöllke, Marco Zecca, et al.
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2013
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental GroupRudolph Kirk R Schultz, Kevin Scott Baker, Jaap J Boelens, et al.
Haematologica|February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemiaSandra Preuner, Christina Peters, Ulrike Pötschger, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Blood|May 25, 2016
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experienceBeatriz Morillo-Gutierrez, Rita Beier, Kanchan Rao, et al.
Haematologica|August 16, 2023
Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndromeMiriam Erlacher, Felicia Andresen, Martina Sukova, et al.
Haematologica|December 9, 2017
Constitutional <i>SAMD9L</i> mutations cause familial myelodysplastic syndrome and transient monosomy 7Victor B Pastor, Sushree S Sahoo, Jessica Boklan, et al.
JCI Insight|May 22, 2024
Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemiaYari Giménez, Manuel Palacios, Rebeca Sánchez-Domínguez, et al.
Blood Advances|January 20, 2026
Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent yearsFelicia Andresen, Ayami Yoshimi, Peter Bader, et al.
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Blood|September 9, 2004
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trialFranco Locatelli, Peter Nöllke, Marco Zecca, et al.
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2013
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental GroupRudolph Kirk R Schultz, Kevin Scott Baker, Jaap J Boelens, et al.
Haematologica|February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemiaSandra Preuner, Christina Peters, Ulrike Pötschger, et al.
Pageof 10